The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Lipoprotein receptors in the liver. Control signals for plasma cholesterol traffic.
Open accessAbstract
A decade of intense investigation has established a central role for lipoprotein receptors in regulating plasma cholesterol traffic. These receptors bind cholesterol-carrying lipoproteins and transport them into cells by receptor-mediated endocytosis. The receptor for low density lipoprotein (LDL) was the first discovered; it has been purified and its structure characterized. The LDL receptor was described in cultured human fibroblasts; identical receptors are now known to function in liver as well as in extrahepatic tissues. Operationally, the LDL/LDL receptor system can be considered the primary transport mechanism for endogenous cholesterol. Dietary cholesterol, on the other hand, is transported from the intestine in chylomicron remnants, which enter hepatocytes via distinct chylomicron remnant receptors. The chylomicron remnant/remnant receptor system is to exogenous cholesterol transport as the LDL/LDL receptor system is to endogenous cholesterol transport. In this article, we review recent developments in this rapidly advancing field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“While LDL biology is mostly relevant for peripheral diseases32,54,55”
From Decreased lipidated ApoE‐receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes (2025) · cites this paper as [54]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,908
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
Regulation of Plasma Cholesterol by Lipoprotein Receptors
Brown, M. S., Kovanen, P. T., & Goldstein, J. L. (1981) · Science · doi:10.1126/science.6261329 · Cited by 702
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Windler, E. E. T., Kovanen, P. T., Chao, Y. S., Brown, M. S., Havel, R. J., & Goldstein, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70487-6 · Cited by 456
Self-citationSherrill, B. C., Innerarity, T. L., & Mahley, R. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85951-3 · Cited by 426
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.
Kovanen, P. T., Bilheimer, D. W., Goldstein, J. L., Jaramillo, J. J., & Brown, M. S. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.1194 · Cited by 421
Self-citationLipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69254-9 · Cited by 383
Research works printed but not linked: 13
- [4]4. Kita, T., J. L. Goldstein, M. S. Brown, Y. Watanabe, C. A. Hornick, and R. J. Havel. 1982. Proc. Natl. Acad. Sci. USA. 79:3623-3627.
- [11]11. Kovanen, P. T., M. S. Brown, S. K. Basu, D. W. Bilheimer, and J. L. Goldstein. 1981. Proc. Natl. Acad. Sci. USA. 78:1396-1400.
- [3]3. percholesterolemia. Chapter 33. In The Metabolic Basis of Inherited Disease. J. B. Stanbury, J. B. Wyngaarden, D. S. Fredrickson, J. L. Goldstein, and M. S. Brown, editors. Fifth ed. McGraw-Hill Book Co., New York. 672-712.
- [12]12. Angelin, B., C. A. Raviola, T. L. Innerarity, and R. W. 34. Bilheimer, D. W., Y. Watanabe, and T. Kita. 1982. Proc. Mahley. 1983. J. Clin. Invest. 71:816-831. Natl. Acad. Sci. USA. 79:3305-3309.
- [14]14. Bilheimer, D. W., S. M. Grundy, M. S. Brown, and J. L. Goldstein. 1983. Proc. Natl. Acad. Sci. USA. In press.
- [16]16. Kovanen, P. T., D. W. Bilheimer, J. L. Goldstein, J. J. Jaramillo, and M. S. Brown. 1981. Proc. Natl. Acad. Sci. USA. 78:1194-1198.
- [18]18. Thompson, G. R., A. K. Soutar, F. A. Spengel, A. Jadhav, S. J. P. Gavigan, and N. B. Myant. 1981. Proc. Natl. Acad. Sci. USA. 78:2591-2695.
- [22]22. Goldstein, J. L., T. Kita, and M. S. Brown. 1983. N. Engl. J. Med. In press.
- [36]36. Mahley, R. W., K. H. Weisgraber, G. W. Melchior, T. L. Innerarity, and K. S. Holcombe. 1980. Proc. Natl. Acad. Sci. USÁ. 77:225-229.
- [40]40. Mahley, R. W., and B. Angelin. 1983. Adv. Intern. Med. In press.
- [43]43. Rall, S. C., Jr., K. H. Weisgraber, T. L. Innerarity, and R. W. Mahley. 1982. Proc. Natl. Acad. Sci. USA. 79:4696-4700.
- [46]46. Havel, R. J., Y-S. Chao, E. E. Windler, L. Kotite, and L. S. S. Guo. 1980. Proc. Natl. Acad. Sci. USA. 77:43494353.
- [53]53. Bilheimer, D. W., S. M. Grundy, M. S. Brown, and J. L. Goldstein. 1983. Trans. Assn. Am. Phys. In press.
Cited by
Sorted by citations
Items 501–545 of 545
Mahley, R. W. (1987) · Proceedings in life sciences · doi:10.1007/978-3-642-71702-4_11
Lipoprotein Receptors and Their Ligands: Structure and Function of Apoproteins E and B
Mahley, R. W. (1987) · Springer eBooks · doi:10.1007/978-3-642-83118-8_2
Bile Acids, Lipoproteins, and Atherosclerosis
Angelin, B. (1987) · Springer eBooks · doi:10.1007/978-3-642-71753-6_22
The Case of the Common Duct Stone
DePalma, R. G. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.12.1398
Apolipoproteine E humaine: polymorphisme et domaine de fixation aux récepteurs
Bekaert, E. D., Ayrault-Jarrier, M., & Polonovski, J. (1986) · Biochimie · doi:10.1016/s0300-9084(86)80157-2
Babaev, V. R., & Kosykh, V. A. (1989) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00837080
Genetic and metabolic studies of APOE, PCSK9, TM6SF2 and PNPLA3
Mahdessian, H. (2014) · Figshare
Sánchez-Cuén, J. A., Ramos‐Payán, R., Cabrales, A. B. I., Aguilar‐Medina, M., García, B., & Bracamontes, S. T. (2010) · Redalyc (Universidad Autónoma del Estado de México)
Dietary fish oil and experimental atherosclerosis
Hartog, J. M. (1989) · RePub (Erasmus University Rotterdam)
A Serendipidade na Medicina e na Anestesiologia * Serendipity in Medicine and Anesthesiology
Bezerra, N. X., Delfino, J., Flávio, L., & do Vale, B. (2005)
Brissette, L., & Noël, S. P. (1988) · Biochemistry and Cell Biology · doi:10.1139/o88-142
Al-Saffar, A.-M. H., Al-Muhammadi, M. O., & Alwash, S. M. (2012) · Medical Journal of Babylon
Evaluation of the clinical significance of the discovery of the LDL receptor
Grundy, S. M. (1987) · Springer eBooks · doi:10.1007/978-94-009-3205-0_1
Stürmer, W., Kromer, E. P., Riegger, A. J. G., & KOCHSIEK, K. (1991) · Journal of Molecular Medicine · doi:10.1007/bf01644764
de Freitas, M. C. P. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2015.tde-17092015-094133
Fonksiyonel Besinlerin Kolesterol Metabolizması Üzerinde Etkisi
Almasi, N., & Fisunoğlu, M. (2020) · Hacettepe Üniversitesi Sağlık Bilimleri Fakültesi Dergisi · doi:10.21020/husbfd.474381
Lipoproteins, apoprotein A-1 containing particles and the development of atherosclerosis
Vallance, D. T. (1993) · UCL Discovery (University College London)
Raghuwanshi, P. K. P., Rastogi, A. L. K. A., Singh, D. C. V. P., & Wazir, S. K. V. S. (2019) · International Journal of Current Microbiology and Applied Sciences · doi:10.20546/ijcmas.2019.808.118
Management of the Hyperlipidemia of the Nephrotic Syndrome
Grundy, S. M., & Vega, G. L. (1990) · Springer eBooks · doi:10.1007/978-1-4613-1491-2_4
Raasch, R. H. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_73
The Liver in the Neonate, in Infancy and Childhood
Kelly, D. A. (2011) · doi:10.1002/9781444341294.ch29
SHORT COMMUNICATION/KURZMITTEILUNG
(1986) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1986.24.5.353
SCHETTLER, G. F. (1986) · Springer eBooks · doi:10.1007/978-3-642-46583-3_2
Reflecting on 80 years of excellence
Savla, U. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423290
SCHETTLER, G. F. (1986) · Springer eBooks · doi:10.1007/978-3-642-46583-3_1
The Interplay of Iron and Lipid Homeostasis in Non-Alcoholic Fatty Liver Disease
Kidman, C. J., Mamotte, C. D. S., Inder-Smith, K. R., Tobin, M. J., Hackett, M. J., & Graham, R. M. (2024) · Journal of Renal and Hepatic Disorders · doi:10.15586/jrenhep.v8i1.170
Plants-bearing essential oils and their phytochemical contents
Cebe, D. B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24860-3.00010-0
Nakano, T., Harano, Y., Hidaka, H., Kosugi, K., Kojima, H., Harada, M., & Shigeta, Y. (1987) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.15.4_879
Measurement of Apolipoprotein E and C-II by Single Radial Immunodiffusion
MIYAHARA, T., MURAI, A., FUJIMOTO, N., Matsuda, M., & Kameyama, M. (1984) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.12.5_1229
Effects of Simvastatin and Pravastatin on the Composition of Lipoproteins
SASAKI, N., Saitō, Y., & YOSHIDA, S. (1994) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.22.4_307
Suzukawa, M., NAMIKI, M., Nishiwaki, M., Ikewaki, K., Hirata, F., Kondo, K. N., MIYAJIMA, E., & Nakamura, H. (1988) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.16.4_483
Rajaratnam, R. (2000) · Työväentutkimus Vuosikirja
Yoshida, H., Suzukawa, M., Hosoai, H., Shige, H., TOMIYASU, K., Yamashita, T., Nishio, E., Itou, T., Nakajima, K., NAMIKI, M., et al. (1991) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.19.12_1057
Characterization of Hepatitis C Virus interaction with heparan sulfate proteoglycans
Xu, Y. (2014) · theses.fr (ABES) · doi:10.70675/b8c9dc27z15cfz4921zad5czee757d47d341
Hypertriglycéridémie postprandiale : signature microARN et insulino-résistance
housseini, R. E. (2019) · theses.fr (ABES) · doi:10.70675/7d24ea93z83a6z478aza78dzaa7adafeb958
Hemel, N. H., Nyeem, T. A., Sultana, N., Rabby, B. U., Shahin, M. S. H., Alsolami, K., Hawlader, Y., Tabrez, S., Hossain, M. I., & Siddiquee, N. H. (2026) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-026-00809-0
Atherosclerosis: Pathology, Pathogenesis, and Medical Management
Chau, M. H., Chin, A. L., & O’Connell, J. B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-28432-8.00006-5
The effects of dietary fat quality on cholesterol and lipoprotein metabolism in the guinea pig
Ibrahim, J. B. T. (1990) · UA Campus Repository (The University of Arizona)
The influence of diet and drugs of cholesterol metabolism in the liver
Barbara, L., Roda, E., Malavolti, M., Simoni, P., Mazzella, G., Borghi, G., & Roda, A. (1987) · Springer eBooks · doi:10.1007/978-94-009-3205-0_34
Storia del concetto biologico di aterosclerosi
Riva, M. A. (2010) · Springer eBooks · doi:10.1007/978-88-470-1412-1_2
Metadata
- Authors
- Brown, M. S., & Goldstein, J. L.
- ORCID
- Goldstein, J L
- Venue
- Journal of Clinical Investigation
- Published
- 1983-09-01
- Volume
- 72
- Issue
- 3
- Pages
- 743-747
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1129238
- OpenAlex
- W2137716547
- Cited by
- 545
- References
- 48
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 5 · 2020: 9 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 1 · 2015: 6 · 2014: 9 · 2013: 5 · 2012: 13
- FWCI
- 66.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (HL20948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- lipoprotein receptors, liver, LDL receptor, receptor-mediated endocytosis, chylomicron remnants, dietary cholesterol, hepatocytes
- MeSH terms
- Animals, Apolipoproteins, Apolipoproteins E, Apoproteins, Binding, Competitive, Cholesterol, Cyclohexanones, Dogs, Guinea Pigs, Cricetinae, Humans, Hyperlipoproteinemia Type II, Liver, Macaca mulatta, Molecular Weight, Rabbits, Receptors, Cell Surface, Receptors, LDL, Receptors, Lipoprotein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review